FTC sues major pharmacy benefit managers around insulin price ranges The company brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of daily life-conserving insulin medicines. Hear the report 10 min This audio is auto-created. You should allow https://jaidensjzof.blogminds.com/everything-about-healthcare-news-28244727